A previous study demonstrated that upregulated miR-181b-5p could promote cell proliferation, migration, and invasion by targeting PARK2 via the PTEN/PI3K/AKT pathway in cholangiocarcinoma (Jiang et al., 2021). Here, PRKN is linked to cholangiocarcinoma.